NASDAQ Welcomes NephroGenex (NASDAQ:NRX) to The NASDAQ Stock Market

[GlobeNewswire] – NEW YORK — The NASDAQ OMX Group, Inc. announced that trading of NephroGenex , a drug development company focusing on kidney disease, commenced on The NASDAQ Stock Market on February 11, 2014. more

View todays social media effects on NDAQ

View the latest stocks trending across Twitter. Click to view dashboard

See who The is hiring next, click here to view